Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment

Breast Cancer Research

Volumn 12, Issue 5, 2010, Pages

  Weng, Desheng ^a   Cunin, Monique C ^a   Song, Baizheng ^a   Price, Brendan D ^b   Eller, Mark S ^a   Gilchrest, Barbara A ^a   Calderwood, Stuart K ^b   Gong, Jianlin ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE; BETA GALACTOSIDASE; DNA; GUANINE NUCLEOTIDE; HISTONE H2AX; OLIGONUCLEOTIDE; PYRIMIDINE NUCLEOTIDE; TELOMERE HOMOLOG OLIGONUCLEOTIDE; UNCLASSIFIED DRUG; BETA GALACTOSIDE; BETA-GALACTOSIDE; GALACTOSIDE; H2AX PROTEIN, MOUSE; HISTONE; RADIOSENSITIZING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INHIBITION; CANCER RADIOTHERAPY; CARCINOMA CELL; CELL AGING; CELL COUNT; CELL SURVIVAL; CLONOGENIC ASSAY; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DNA FRAGMENTATION; FEMALE; HISTONE PHOSPHORYLATION; IMMUNOFLUORESCENCE; IONIZING RADIATION; MOUSE; NICK END LABELING; NONHUMAN; OLIGONUCLEOTIDE THERAPY; RADIOSENSITIZATION; TELOMERE; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; MULTIMODALITY CANCER THERAPY; PHOSPHORYLATION; RADIATION DOSE; RADIATION EXPOSURE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL AGING; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINED MODALITY THERAPY; COMET ASSAY; DNA DAMAGE; FEMALE; GALACTOSIDES; HISTONES; IN SITU NICK-END LABELING; MAMMARY NEOPLASMS, ANIMAL; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDES; PHOSPHORYLATION; RADIATION TOLERANCE; RADIATION, IONIZING; RADIATION-SENSITIZING AGENTS; TELOMERE;

EID: 78650870307     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2639     Document Type: Article

References (36)

1. McClintock B. The stability of broken ends of chromosomes in Zea mays. Genetics 1941, 26:234-282. 1209127, 17247004.
2. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002, 295:2446-2449. 10.1126/science.1069523, 11923537.
3. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999, 283:1321-1325. 10.1126/science.283.5406.1321, 10037601.
4. de Lange T. Protection of mammalian telomeres. Oncogene 2002, 21:532-540. 10.1038/sj.onc.1205080, 11850778.
5. Eller MS, Puri N, Hadshiew IM, Venna SS, Gilchrest BA. Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res 2002, 276:185-193. 10.1006/excr.2002.5531, 12027448.
6. Puri N, Eller MS, Byers HR, Dykstra S, Kubera J, Gilchrest BA. Telomere-based DNA damage responses: a new approach to melanoma. Faseb J 2004, 18:1373-1381. 10.1096/fj.04-1774com, 15333580.
7. Ohashi N, Yaar M, Eller MS, Truzzi F, Gilchrest BA. Features that determine telomere homolog oligonucleotide-induced therapeutic DNA damage-like responses in cancer cells. J Cell Physiol 2007, 210:582-595. 10.1002/jcp.20848, 17133364.
8. Yaar M, Eller MS, Panova I, Kubera J, Wee LH, Cowan KH, Gilchrest BA. Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells. Breast Cancer Res 2007, 9:R13. 10.1186/bcr1646, 1851376, 17257427.
9. Aoki H, Iwado E, Eller MS, Kondo Y, Fujiwara K, Li GZ, Hess KR, Siwak DR, Sawaya R, Mills GB, Gilchrest BA, Kondo S. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. Faseb J 2007, 21:2918-2930. 10.1096/fj.06-6941com, 17449721.
10. Eller MS, Li GZ, Firoozabadi R, Puri N, Gilchrest BA. Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. Faseb J 2003, 17:152-162. 10.1096/fj.02-0197com, 12554694.
11. Longe HO, Romesser PB, Rankin AM, Faller DV, Eller MS, Gilchrest BA, Denis GV. Telomere homolog oligonucleotides induce apoptosis in malignant but not in normal lymphoid cells: mechanism and therapeutic potential. Int J Cancer 2009, 124:473-482. 10.1002/ijc.23946, 2888476, 19003960.
12. Gilchrest BA, Eller MS. Cancer therapeutics: smart and smarter. Drugs of the Future 2009, 34:205-216.
13. Sobeck A, Stone S, Costanzo V, de Graaf B, Reuter T, de Winter J, Wallisch M, Akkari Y, Olson S, Wang W, Joenje H, Christian JL, Lupardus PJ, Cimprich KA, Gautier J, Hoatlin ME. Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks. Mol Cell Biol 2006, 26:425-437. 10.1128/MCB.26.2.425-437.2006, 1346898, 16382135.
14. Wang LC, Stone S, Hoatlin ME, Gautier J. Fanconi anemia proteins stabilize replication forks. DNA Repair (Amst) 2008, 7:1973-1981. 10.1016/j.dnarep.2008.08.005, 2596863, 18786657.
15. Rowse GJ, Tempero RM, VanLith ML, Hollingsworth MA, Gendler SJ. Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res 1998, 58:315-321.
16. Xia J, Tanaka Y, Koido S, Liu C, Mukherjee P, Gendler SJ, Gong J. Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells. J Immunol 2003, 170:1980-1986.
17. Amorino GP, Mikkelsen RB, Valerie K, Schmidt-Ullrich RK. Dominant-negative cAMP-responsive element-binding protein inhibits proliferating cell nuclear antigen and DNA repair, leading to increased cellular radiosensitivity. J Biol Chem 2003, 278:29394-29399. 10.1074/jbc.M304012200, 12734192.
18. Lee JH, Kang Y, Khare V, Jin ZY, Kang MY, Yoon Y, Hyun JW, Chung MH, Cho SI, Jun JY, Chang IY, You HJ. The p53-inducible gene 3 (PIG3) contributes to early cellular response to DNA damage. Oncogene 2010, 29:1431-1450. 10.1038/onc.2009.438, 20023697.
19. Itahana K, Campisi J, Dimri GP. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol 2007, 371:21-31. full_text, 17634571.
20. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995, 92:9363-9367. 10.1073/pnas.92.20.9363, 40985, 7568133.
21. Chen D, Koido S, Li Y, Gendler S, Gong J. T cell suppression as a mechanism for tolerance to MUC1 antigen in MUC1 transgenic mice. Breast Cancer Res Treat 2000, 60:107-115. 10.1023/A:1006332009414, 10845273.
22. Jaskelioff M, Song W, Xia J, Liu C, Kramer J, Koido S, Gendler SJ, Calderwood SK, Gong J. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene 2009, 28:4225-4236. 10.1038/onc.2009.268, 19734944.
23. Malaise EP, Fertil B, Chavaudra N, Guichard M. Distribution of radiation sensitivities for human tumor cells of specific histological types: comparison of in vitro to in vivo data. Int J Radiat Oncol Biol Phys 1986, 12:617-624. 10.1016/0360-3016(86)90071-4, 3009370.
24. Kinner A, Wu W, Staudt C, Iliakis G. Gamma-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin. Nucleic Acids Res 2008, 36:5678-5694. 10.1093/nar/gkn550, 2553572, 18772227.
25. Eller MS, Liao X, Liu S, Hanna K, Backvall H, Opresko PL, Bohr VA, Gilchrest BA. A role for WRN in telomere-based DNA damage responses. Proc Natl Acad Sci USA 2006, 103:15073-15078. 10.1073/pnas.0607332103, 1586178, 17015833.
26. Eastham AM, Marples B, Kiltie AE, Orton CJ, West CM. Fibroblast radiosensitivity measured using the comet DNA-damage assay correlates with clonogenic survival parameters. Br J Cancer 1999, 79:1366-1371. 10.1038/sj.bjc.6690219, 2374263, 10188877.
27. Jaskelioff M, Song W, Xia J, Liu C, Kramer J, Koido S, Gendler SJ, Calderwood SK, Gong J. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene 2009, 28:4225-4236. 10.1038/onc.2009.268, 19734944.
28. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, Pollard JW. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003, 163:2113-2126. 1892434, 14578209.
29. Zhou BB, Elledge SJ. The DNA damage response: putting checkpoints in perspective. Nature 2000, 408:433-439. 10.1038/35044005, 11100718.
30. Rich T, Allen RL, Wyllie AH. Defying death after DNA damage. Nature 2000, 407:777-783. 10.1038/35037717, 11048728.
31. Schmitt CA. Senescence, apoptosis and therapy--cutting the lifelines of cancer. Nat Rev Cancer 2003, 3:286-295. 10.1038/nrc1044, 12671667.
32. Li GZ, Eller MS, Firoozabadi R, Gilchrest BA. Evidence that exposure of the telomere 3' overhang sequence induces senescence. Proc Natl Acad Sci USA 2003, 100:527-531. 10.1073/pnas.0235444100, 141029, 12515865.
33. Castella M, Puerto S, Creus A, Marcos R, Surralles J. Telomere length modulates human radiation sensitivity in vitro. Toxicol Lett 2007, 172:29-36. 10.1016/j.toxlet.2007.05.012, 17604920.
34. Woodford KJ, Howell RM, Usdin K. A novel K(+)-dependent DNA synthesis arrest site in a commonly occurring sequence motif in eukaryotes. J Biol Chem 1994, 269:27029-27035.
35. Li GZ, Eller MS, Hanna K, Gilchrest BA. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res 2004, 301:189-200. 10.1016/j.yexcr.2004.08.019, 15530855.
36. Hall EJ, Giaccia AJ. Radiobiology for the Radiologist 2006, Philadelphia: Lippincott Wilkins & Williams.